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Background: The mental health status of a pregnant woman and its consequent impact on foetal well being is not
given much importance compared to the risk imposed by obstetric complications and medical conditions. Maternal
psychological distress is a major public health problem and needs timely detection and intervention to prevent any
adverse pregnancy outcome. There is ample evidence from literature that justifies the association of prenatal
maternal mental stress and elevated cortisol with delayed infant motor and cognitive development; evidence from
India being rather limited. The study aim is to prospectively assess the association of maternal psychological distress
and cortisol level with motor and cognitive development of the infant.
Methods: A sample of 2612 eligible pregnant women who have been registered for antenatal care at selected
public sector hospitals in Bengaluru will be recruited after obtaining written informed consent. They will be
assessed for the presence of maternal psychological distress in the form of depression and anxiety using
appropriate scales and saliva samples will be collected for cortisol estimation during early, mid and late pregnancy.
Follow up visits after delivery will be done on day 10, 3 months, 8 months and 12 months. The Bayley Scales of
Infant and Toddler Development [BSID] (Third edition) will be used to measure both motor and mental milestones
in terms of Psychomotor Development Index (PDI) and Mental Development Index (MDI). Logistic regression model
will be used to determine the association between the exposure variables and outcomes which will be reported as
Odd’s Ratio (OR) and 95% confidence intervals (CI).
Discussion: Our study findings could add to the growing evidence that maternal psychological distress during
pregnancy adversely influences growth and development in the offspring and subsequent development of the
child. While maternal anxiety and depression can be measured by using self reporting instruments, estimation of
maternal endogenous cortisol levels could serve as a biomarker of prenatal psychological stress. Findings from this
study could be used to focus upon the burden of mental health problems during pregnancy and to consider steps
to scale up prenatal mental health services in health care settings.
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Pregnancy is a time of physiologic, mental and emotional
change. As a result, women are highly vulnerable to psy-
chological distress that includes anxiety, depression and
stress [1–3]. During this phase of complex and dynamic
changes, the fetal organs and organ systems that are form-
ing are subject to both positive and negative influences,
also known as foetal programming [4]. There is ample evi-
dence from literature that justifies the association of pre-
natal maternal stress with delayed infant motor and
cognitive development wherein it has been reported that
high levels of maternal stress during mid-pregnancy was
significantly associated with lower scores of motor and
mental development of the infant [5–8].
Prenatal maternal stress has been frequently linked
with elevated levels of maternal endogenous cortisol [9].
The cortisol hormone plays an important role in normal
development of the foetus [10]. During pregnancy, the
maternal cortisol levels increase by two to four times
[11]. This increase has a positive influence on neural de-
velopment [12]. However, foetal exposure to excess ma-
ternal cortisol may result in impaired brain development
as a result of neurotoxicity [13, 14]. Animal studies show
that exposure to prenatal stress induced a significant rise
in maternal cortisol secretion by activating the maternal
Hypothalamo Pituitary Axis (HPA). Elevated levels of
cortisol reach the foetus and modify the activity of foetal
HPA axis [15–17]. This modification of the foetal HPA
axis exerts a detrimental effect on further growth and
development through a series of complex endocrine
mechanisms [18–20]. In animals, prenatal stress also ex-
erts an inhibitory effect on the placental enzyme 11 β-
hydroxysteroid-dehydrogenase type 2 which converts
maternal cortisol to inactive cortisone resulting in a rise
in amniotic fluid cortisol level which affects foetal HPA
functioning [21].
The evidence of association of prenatal stress with ele-
vated maternal cortisol levels in humans is rather weak
[22–24]. Nevertheless, there are few studies that have
evaluated the effect of prenatal exposure to elevated ma-
ternal cortisol on infant outcomes and observed an ad-
verse effect on infant development and lower scores of
IQ in childhood [5, 7, 25]. The timing of exposure to el-
evated maternal cortisol during the gestational period
appears to be of significance. While one such study ob-
served poor infant neuromotor development to be asso-
ciated with exposure early in pregnancy, another one
reported a significant association with exposure in the
third trimester [5, 7].
While most of the studies have relied on maternal self
reporting of psychological distress to establish its linkage
with adverse infant outcome, there are a few studies in
which prenatal stress did not appear to influence infant
and child development [26, 27]. Thus, this kind of selfreporting may have its own limitation in quantifying
stress during pregnancy [5, 28]. Few of the studies have
used both measures for establishing the presence of pre-
natal stress i.e., self reporting and measurement of ma-
ternal cortisol and observed an independent significant
association with adverse infant and child outcomes in
each case [5, 7, 29–31].
Evidence from India that depicts the association of
prenatal stress with infant and child development is
rather limited. A study done in Goa observed the ex-
istence of a positive association between psychological
morbidity during pregnancy and low birth weight
[32]. Another study done in India found prenatal ma-
ternal anxiety to be linked with elevated infant corti-
sol reactivity [33]. In another study which was
undertaken to explore the relationship between pre-
natal stress and infant temperament, it was seen that
although the levels of salivary cortisol was high in
those infants whose mothers were psychologically dis-
tressed, there was no significant association with ma-
ternal reports of infant temperament [34]. However,
these studies have not explored the effect of prenatal
stress and maternal cortisol level on the mental and
motor development of the offspring.
The prevalence of maternal prenatal depression has
been observed to be a little higher than 25% in low
and middle income countries [35, 36]. While core im-
portance towards screening for obstetric risk factors
and medical conditions is the norm in most settings;
mental health of the pregnant women and its conse-
quent impact on foetal well being tends to be over-
looked. Maternal psychological distress is therefore a
major public health problem and needs timely detec-
tion and intervention to prevent any adverse preg-
nancy outcome.
Given the above background, the aim of this study is
to prospectively assess the association of maternal psy-
chological distress and cortisol level with motor and
cognitive development of the infant. The objectives in-
clude: (i) to describe the pattern of occurrence of mater-
nal psychological distress during pregnancy (ii) to
determine the influence of maternal psychological dis-
tress on infant motor and cognitive development (iii) to
determine the influence of maternal cortisol level on in-
fant motor and cognitive development. (iv) to correlate
maternal psychological distress with maternal cortisol
levels.
The proposed hypotheses are as follows:
Hypothesis 1: Maternal self reported psychological dis-
tress is associated with adverse infant motor and cogni-
tive development.
Hypothesis 2: Elevated maternal cortisol level is
associated with adverse infant motor and cognitive
development.
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the exposure, outcome and potential confounders is out-
lined in Fig. 1.
Methods/design
Study design: Prospective cohort study
Study participants and study setting
The study participants will include eligible pregnant
women attending the antenatal clinic at the Jaya Nagar
general hospital, Bangalore, who fulfill the following in-
clusion criteria which include (i) age between 18 and
40 years (ii) between 14 weeks to 28 weeks of gestation
(iii) plan to deliver in the study hospital (iv) permanently
residing in the study area within a radius of 15 km
(v) full term healthy neonate with Apgar score of more
than 7. Exclusion criteria will include (i) Multiple preg-
nancy (ii) grand multipara (iii) major pregnancy complica-
tions: preeclampsia-eclampsia, hyperemesis gravidarum
(iv) birth complications: still births, preterm delivery, con-
genital anomalies (v) History of past or present intake of
steroid medications.
Sample size
Evidence from literature shows that 10% to 20% of all
women suffer from depression or anxiety during preg-
nancy [37, 38]. With an expected prevalence of 15%, an
allowable error of 5%, 10% variability and power 80%,
the sample size is calculated to be 2176. Assuming a
drop out rate of 20%, the calculated sample size amounts
to 2612.
Sampling method
All those pregnant women who are visiting the antenatal
clinic will be screened for eligibility. The women whoFig. 1 Conceptual Framework to depict Hypotheses 1 and 2are found to be eligible will be enlisted every month.
They will be selected to participate in the study by
means of simple random sampling, by using a series of
computer generated numbers. The selected women will
be contacted over the phone and invited to come to the
study hospital. If a selected woman denies to enter the
study, the woman then with the next number will be in-
vited to participate.
Study procedures
The selected women would be recruited into the study
after obtaining a written informed consent from them.
The baseline assessment will be done at the time of re-
cruitment between 14 and 28 weeks (early to mid preg-
nancy). A. questionnaire will be administered to collect
data on socio-demographic characteristics, obstetric,
medical and psychiatric past histories.
Further assessments will be done (i) 37–38 weeks of
gestation (late pregnancy), and at (ii) 10 days (iii) 3,
8 months (iv) 12 months after birth.
A flowchart depicting the study steps is shown in
Fig. 2.
Measurement of study exposure and outcomes
Maternal psychological distress
The presence of maternal psychological distress will be
identified by using Kessler 10 Scale of Psychological
Distress (K10) for prenatal depression [39] and the 10-
item Pregnancy related anxiety (PRA) scale for preg-
nancy anxiety [40]. The K10 scale is well structured and
includes questions about anxiety and depressive symp-
toms that a person has experienced in the most recent
4 week period. Each question has five response categor-
ies ranked on a five-point scale, with the score being the
Fig. 2 Flowchart depicting steps of the cohort study
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cerns and worries that are specific to pregnancy and
childbirth. The scoring on this scale ranges from 10 to
40. These assessments will be done at (i) Baseline visit -
between 14 and 28 weeks (ii) Second visit: 37–38 weeks.
The levels of the unbound cortisol hormone in
blood is reliably reflected by salivary cortisol levels
[41]. Maternal saliva samples will be collected for cor-
tical analyses at (i) Baseline visit - between 14 and
28 weeks (ii) Second visit: 37–38 weeks.
The salivary samples will be stored until assayed at
−70 °C, in a Biorepository facility at the St. Johns
Research Institute. The evaluation of the samples will be
done at an NABL (National Accreditation Board for
Testing and Calibration Laboratories) accredited Lab.
Before assay, the samples are thawed and centrifuged for
about 15 min. The cortisol levels are estimated by a
competitive luminescence immunoassay with a lower
limit of detection of 0.5 nmol/L [42]. The infant will be
assessed at 3, 8 and 12 months for developmental
indices by the Bayley Scales of Infant and Toddler
Development (BSID), Third edition which measures both
motor and mental milestones [43]. This will be accom-
plished by means of home visits. The Bayley scales coverfive major areas of development - cognitive, communica-
tion, physical, socio-emotional and adaptive. The scales
to measure the cognitive and physical areas of develop-
ment will be used. The weight and length of the infant
will also be recorded during these visits.
All the psychometric measurement scales and BSID
will be translated into the local language ‘Kannada’
using the standardised WHO translation and back-
translation protocol (WHO) and pre-tested before be-
ing finalized [44].
The Research team will receive training for using these
scales from a team of experts at CSI Holdsworth
Memorial Hospital, Mysore.
Confounders
The confounding factors that influence the outcome
variables- cortisol level and infant growth and develop-
ment will be taken into account at the time of data ana-
lysis. These are enlisted in Fig. 1. Data on maternal
educational level, occupation, socio-economic status,
pregnancy risk factors will be obtained from the baseline
information. The gestational age will be calculated from
the last menstrual period as reported by the study par-
ticipants. Information on birth weight will be obtained
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post-natal psychological well-being and post-natal de-
pression will be collected at the 10th day visit after birth.
Maternal psychological well being will be assessed by
using the General Health Questionaiire-30 which mea-
sures one’s ability for effective daily functioning [45].
This contains 30 questions which are answered on a 4-
point scale. Post natal depression will be measured by
using the 10-item Edinburgh Postnatal Depression Scale
(EPDS) [46].
Data management and analysis
Data management will be done using Microsoft Access
which will be transported to SPSS Version 24 for ana-
lysis. Descriptive statistics will be used to summarize the
socio-demographic characteristics, obstetric variables,
perinatal outcomes, scores obtained from measurement
scales and cortisol level estimates. Confounding variables
will be tested for their relationships with the exposure
(Maternal anxiety, depression and salivary cortisol
level) and outcome (Mental Development Index and
Psychomotor Development Index) by means of corre-
lations (Pearson correlation coefficient or Spearman
rank-order correlations where appropriate) and re-
gression analysis. Only those variables that are signifi-
cantly related to the exposure and outcome will be
included in further analyses. Logistic Regression
Model will be used to determine the association be-
tween the exposure variables and outcome which will
be reported as Odd’s Ratio (OR) and 95% confidence
intervals (CI). The statistical significance for all the
tests will be assumed to be at the level of P < .05.
Ethical considerations
The protocol for the proposed study has been reviewed
and approved by the institutional ethical review board
(IEC) at Bengaluru campus of IIPH-H. All the study par-
ticipants will be required to provide a written informed
consent in the local language.
Discussion
Our study findings could add to the growing evidence
that maternal psychological distress during pregnancy
adversely influences growth and development in the off-
spring and subsequent development of the child. While
maternal anxiety and depression can be measured by
using self reporting instruments, estimation of maternal
endogenous cortisol levels could serve as a biomarker of
prenatal psychological stress. Perhaps a combination of
the above mentioned subjective and objective measures
could give a better measure of mental stress during the
antenatal period.
The findings from this study could be used to focus
upon the burden of mental health problems duringpregnancy with its adverse consequences and to consider
steps to scale up prenatal mental health services in both
public as well as private health settings. The study find-
ings could be used to plan for evidence based- interven-
tions such as stress reduction programmes to reduce
maternal anxiety and depression during pregnancy, par-
ticularly in the Indian scenario.
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